We are live on ! Find out more
PBTH

PROLOR Biotech, Inc. Common Stock
PBTH

Delisted

PBTH was delisted on the 29th of August, 2013.

Back to rankings

41 hedge funds and large institutions have $44.3M invested in PROLOR Biotech, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

353% more call options, than puts

Call options by funds: $612K | Put options by funds: $135K

Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
–
Reduced
–
Closed
–
Calls
$612K
Puts
$135K
Net Calls
+$477K
Net Calls Change
+$477K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

PBTH Hedge Fund Activity: Q2 2013 in Review

41 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in PROLOR Biotech, Inc. Common Stock (PBTH) for Q2 2013, worth a combined $44.3M.

Buyers outnumbered sellers: 41 funds opened new PBTH positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

  • 41 institutional investors held PROLOR Biotech, Inc. Common Stock (PBTH) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $44.3M of PROLOR Biotech, Inc. Common Stock stock for Q2 2013.
  • 41 funds opened new PROLOR Biotech, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +41 holders.

Based on aggregated 13F filings for Q2 2013.